Terms: = Bone cancer AND TRRAP, TR-AP, 8295, ENSG00000196367, Q9Y4A5, PAF400, PAF350/400, FLJ10671, STAF40, Tra1 AND Treatment
630 results:
1. Prognostic significance of occult vertebral fracture in patients undergoing pancreatic resection for pancreatic cancer.
Ishizaki S; Furukawa K; Haruki K; Tsunematsu M; Shirai Y; Matsumoto M; Okui N; Onda S; Taniai T; Ikegami T
Pancreatology; 2024 Mar; 24(2):249-254. PubMed ID: 38218681
[TBL] [Abstract] [Full Text] [Related]
2. Busulfan with 400 centigray of total body irradiation and higher dose fludarabine: An alternative regimen for hematopoietic stem cell transplantation in pediatric acute lymphoblastic leukemia.
Gharial J; Guilcher G; Truong T; Shah R; Desai S; Rojas-Vasquez M; Kangarloo B; Lewis V
Pediatr Blood Cancer; 2024 Apr; 71(4):e30844. PubMed ID: 38217082
[TBL] [Abstract] [Full Text] [Related]
3. Effect of initial recurrence site on the prognosis of different tissue types of non-small cell lung cancer: a retrospective cohort study.
Li Y; Liu L; You R; Li Q; Jiang Z; Pu H; Li Z; Chen X
World J Surg Oncol; 2023 Nov; 21(1):360. PubMed ID: 37986082
[TBL] [Abstract] [Full Text] [Related]
4. Supporting patients in the transition to the revised pexidartinib dosing regimen: perspectives from the multidisciplinary clinical and allied health professional team.
McCabe C; Wright H; Polson K; Wagner AJ
Orphanet J Rare Dis; 2023 Oct; 18(1):313. PubMed ID: 37805596
[TBL] [Abstract] [Full Text] [Related]
5. Gorham-Stout syndrome, the challenge in diagnosis and unique in treatment: a case report.
Saberi S; Bagheri N; Kalantar SH; Saffar H; Khabiri SS
J Med Case Rep; 2023 Aug; 17(1):360. PubMed ID: 37605280
[TBL] [Abstract] [Full Text] [Related]
6. Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
Isfort S; Manz K; Teichmann LL; Crysandt M; Burchert A; Hochhaus A; Saussele S; Kiani A; Göthert JR; Illmer T; Schafhausen P; Al-Ali HK; Stegelmann F; Hänel M; Pfeiffer T; Giagounidis A; Franke GN; Koschmieder S; Fabarius A; Ernst T; Warnken-Uhlich M; Wolber U; Kohn D; Pfirrmann M; Wolf D; Brümmendorf TH;
Ann Hematol; 2023 Oct; 102(10):2741-2752. PubMed ID: 37592092
[TBL] [Abstract] [Full Text] [Related]
7. A rare case of prostate cancer initially presented by disseminated intravascular coagulation-related subdural hemorrhage.
Shafie M; Shahmohamadi E; Hadizadeh A; Hasanzadeh A; Gholampour G; Parsa S
Cancer Rep (Hoboken); 2023 Sep; 6(9):e1868. PubMed ID: 37435692
[TBL] [Abstract] [Full Text] [Related]
8. [Effects of fucoidan inducing impairment of human osteosarcoma cell 143B and its mechanism].
Wang QQ; Lin Q; Shan WY; Zhang T; Li YR; Zhang Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Nov; 38(6):739-744. PubMed ID: 37308428
[No Abstract] [Full Text] [Related]
9. Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia.
Allan JN; Flinn IW; Siddiqi T; Ghia P; Tam CS; Kipps TJ; Barr PM; Elinder Camburn A; Tedeschi A; Badoux XC; Jacobs R; Kuss BJ; Trentin L; Zhou C; Szoke A; Abbazio C; Wierda WG
Clin Cancer Res; 2023 Jul; 29(14):2593-2601. PubMed ID: 37282671
[TBL] [Abstract] [Full Text] [Related]
10. Health-related quality of life and pain outcomes with [
Fizazi K; Herrmann K; Krause BJ; Rahbar K; Chi KN; Morris MJ; Sartor O; Tagawa ST; Kendi AT; Vogelzang N; Calais J; Nagarajah J; Wei XX; Koshkin VS; Beauregard JM; Chang B; Ghouse R; DeSilvio M; Messmann RA; de Bono J
Lancet Oncol; 2023 Jun; 24(6):597-610. PubMed ID: 37269841
[TBL] [Abstract] [Full Text] [Related]
11. Determinants of bone parameters in young paediatric cancer survivors: the iboneFIT project.
Marmol-Perez A; Ubago-Guisado E; Llorente-Cantarero FJ; Vlachopoulos D; Rodriguez-Solana A; Gil-Cosano JJ; Ruiz JR; Gracia-Marco L
Pediatr Res; 2023 Oct; 94(4):1538-1546. PubMed ID: 37202528
[TBL] [Abstract] [Full Text] [Related]
12. bone and Renal Health in Infants With or Without Breastmilk Exposure to Tenofovir-Based Maternal Antiretroviral treatment in the PROMISE Randomized Trial.
Vhembo T; Baltrusaitis K; Tierney C; Owor M; Dadabhai S; Violari A; Theron G; Moodley D; Mukwasi-Kahari C; George K; Shepherd J; Siberry GK; Browning R; Fowler MG; Stranix-Chibanda L;
J Acquir Immune Defic Syndr; 2023 Aug; 93(5):431-437. PubMed ID: 37199427
[TBL] [Abstract] [Full Text] [Related]
13. Sabatolimab (MBG453) model-informed drug development for dose selection in patients with myelodysplastic syndrome/acute myeloid leukemia and solid tumors.
Xu S; Zhang N; Rinne ML; Sun H; Stein AM
CPT Pharmacometrics Syst Pharmacol; 2023 Nov; 12(11):1653-1665. PubMed ID: 37186155
[TBL] [Abstract] [Full Text] [Related]
14. Nicotinamide Adenine Dinucleotide Precursor Suppresses Hepatocellular cancer Progression in Mice.
Pang N; Hu Q; Zhou Y; Xiao Y; Li W; Ding Y; Chen Y; Ye M; Pei L; Li Q; Gu Y; Sun Y; Fang EF; Chen M; Zhang Z; Yang L
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986177
[TBL] [Abstract] [Full Text] [Related]
15. A 68-Year-Old Man with a Cytogenetic Diagnosis of Chronic Myeloid Leukemia and bone Marrow Findings of Philadelphia Chromosome Translocation Between the Long Arm of Chromosomes 9 and 22, Leading to the BCR-ABL1 Fusion Gene and V617F Mutation in the JAK2 Gene.
Warsi A; Alamoudi S; Alsuraihi AK; Althobaiti M; Daghistani M; Samarin K; Alahmadi MO; Abuyabis RG; Bogari RA; Filimban SA
Am J Case Rep; 2023 Mar; 24():e938488. PubMed ID: 36864712
[TBL] [Abstract] [Full Text] [Related]
16. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy].
Lv JB; Yin YP; Zhang P; Cai M; Chen JH; Li W; Li G; Wang Z; Wang GB; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan; 26(1):84-92. PubMed ID: 36650004
[No Abstract] [Full Text] [Related]
17. Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical Trial.
Cafardi J; Miller C; Terebelo H; Tewell C; Benzaquen S; Park D; Egan P; Lebovic D; Pettit K; Whitman E; Tremblay D; Feld J; Buckley S; Roman-Torres K; Smith J; Craig A; Mascarenhas J
JAMA Netw Open; 2022 Dec; 5(12):e2242918. PubMed ID: 36469321
[TBL] [Abstract] [Full Text] [Related]
18. Long-Term Clinical Outcomes of Patients with Colorectal cancer with Metastatic Epidural Spinal Cord Compression Treated with Hybrid Therapy (Surgery Followed by Stereotactic Body Radiation Therapy).
Chakravarthy VB; Schachner B; Amin A; Reiner AS; Yamada Y; Schmitt A; Higginson DS; Laufer I; Bilsky MH; Barzilai O
World Neurosurg; 2023 Jan; 169():e89-e95. PubMed ID: 36272727
[TBL] [Abstract] [Full Text] [Related]
19. Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study.
Fulgenzi CAM; Cheon J; D'Alessio A; Nishida N; Ang C; Marron TU; Wu L; Saeed A; Wietharn B; Cammarota A; Pressiani T; Personeni N; Pinter M; Scheiner B; Balcar L; Napolitano A; Huang YH; Phen S; Naqash AR; Vivaldi C; Salani F; Masi G; Bettinger D; Vogel A; Schönlein M; von Felden J; Schulze K; Wege H; Galle PR; Kudo M; Rimassa L; Singal AG; Sharma R; Cortellini A; Gaillard VE; Chon HJ; Pinato DJ
Eur J Cancer; 2022 Nov; 175():204-213. PubMed ID: 36148739
[TBL] [Abstract] [Full Text] [Related]
20. Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1-2 study.
Bazinet A; Darbaniyan F; Jabbour E; Montalban-Bravo G; Ohanian M; Chien K; Kadia T; Takahashi K; Masarova L; Short N; Alvarado Y; Yilmaz M; Ravandi F; Andreeff M; Kanagal-Shamanna R; Ganan-Gomez I; Colla S; Qiao W; Huang X; McCue D; Mirabella B; Kantarjian H; Garcia-Manero G
Lancet Haematol; 2022 Oct; 9(10):e756-e765. PubMed ID: 36063832
[TBL] [Abstract] [Full Text] [Related]
[Next]
